APA
ABBV icon

American Portfolios Advisors’s AbbVie ABBV Stock Holding History

American Portfolios Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$5.73M Buy
42,730
+5,405
+14% +$776K 0.24% 79
2022
Q2 		$5.72M Sell
37,325
-303
-0.8% -$46.3K 0.23% 81
2022
Q1 		$6.1M Buy
37,628
+3,534
+10% +$513K 0.21% 90
2021
Q4 		$4.62M Buy
34,094
+5,823
+21% +$688K 0.16% 130
2021
Q3 		$3.05M Buy
28,271
+2,719
+11% +$311K 0.11% 182
2021
Q2 		$2.88M Buy
25,552
+3,228
+14% +$364K 0.11% 186
2021
Q1 		$2.42M Buy
22,324
+2,714
+14% +$290K 0.11% 193
2020
Q4 		$2.1M Buy
19,610
+494
+3% +$47.5K 0.11% 187
2020
Q3 		$1.67M Sell
19,116
-1,434
-7% -$135K 0.1% 192
2020
Q2 		$2.02M Buy
20,550
+8,911
+77% +$785K 0.13% 161
2020
Q1 		$887K Buy
11,639
+325
+3% +$27.7K 0.07% 248
2019
Q4 		$1M Buy
11,314
+2,151
+23% +$179K 0.07% 269
2019
Q3 		$694K Sell
9,163
-4,631
-34% -$317K 0.06% 319
2019
Q2 		$1M Buy
13,794
+969
+8% +$76.2K 0.08% 233
2019
Q1 		$1.03M Sell
12,825
-390
-3% -$31.9K 0.1% 210
2018
Q4 		$1.22M Sell
13,215
-2,701
-17% -$238K 0.15% 143
2018
Q3 		$1.51M Sell
15,916
-149
-0.9% -$14.1K 0.17% 118
2018
Q2 		$1.49M Buy
16,065
+285
+2% +$27.8K 0.2% 97
2018
Q1 		$1.49M Sell
15,780
-8,290
-34% -$911K 0.22% 94
2017
Q4 		$2.33M Buy
+24,070
New +$2.27M 0.37% 56

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Portfolios Advisors's ABBV Position: Q3 2022 in Review

American Portfolios Advisors increased its AbbVie (ABBV) stake by 14% in Q3 2022, buying an estimated $776K and bringing the position to 42,730 shares worth $5.73M. The position accounts for 0.24% of the portfolio, ranked #79.

American Portfolios Advisors first reported a position in ABBV in Q4 2017 and has held it in 20 quarters since. The position peaked at $6.1M in Q1 2022. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • American Portfolios Advisors held 42,730 shares of AbbVie worth $5.73M as of Q3 2022.
  • American Portfolios Advisors bought 5,405 AbbVie shares in Q3 2022, an estimated $776K.
  • AbbVie made up 0.24% of American Portfolios Advisors's portfolio in Q3 2022, its #79 holding.
  • American Portfolios Advisors first reported a position in AbbVie in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's AbbVie position peaked at $6.1M in Q1 2022.
  • 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.